Venture Capital

“INNOVATIVE OPPORTUNITIES IN VENTURE CAPITAL INVESTING”

Venture capital and technology investment activity continues to rise, with new technology-enabled business models beginning to exert a transformative effect on the competitive dynamics in many industries. What are the new realities for investors and how are they adapting to the digital revolution and changing competitive dynamics?

 
 
Screen Shot 2019-02-03 at 11.39.41 AM.png
Screen Shot 2019-02-03 at 11.54.25 AM.png

Adele Oliva: ‘93 (MBA)

1315 Capital | Founder

Ms. Oliva has been a healthcare venture investor for over 20 years with a focus on commercial stage medical technology, healthcare service, and specialty pharmaceutical investments. Ms. Oliva co-founded 1315 Capital in 2014 to establish a firm focused on healthcare growth investing. The firm has since raised two funds with over $500 million in total assets under management. Ms. Oliva was recruited to Quaker Partners in 2007 to expand the firm’s growth stage investing practice. Prior to Quaker, Ms. Oliva was Co-Head of U.S. Healthcare at Apax Partners, where she started in 1997.

Forbes recognized Ms. Oliva on its Midas List of top 100 technology investors worldwide, top 10 life science investors, and top women in venture capital.

Ms. Oliva graduated with a Bachelor of Science in Economics from St. Joseph’s University and an M.B.A from Cornell University, where she was awarded the Albert Fried Fellowship.

 
Screen Shot 2019-04-24 at 9.08.37 PM.png
Screen Shot 2019-01-24 at 1.36.09 AM.png

Aaron Holiday: ‘12 (MBA)

645 Ventures | Co-Founder

Mr. Holiday combines years of deep technology expertise, having developed advanced equity trading software and derivative systems at Goldman Sachs and GFI Group, with operational experience working with early-stage founders and CEOs to growth stage companies. As the first Managing Entrepreneurial Officer at Cornell Tech, he has been instrumental in pioneering the campus’ startup and Studio Culture and shepherding deep technology startups toward commercial success. Mr. Holiday built his venture investment experience working directly with the Managing Directors at Gotham Ventures and has been mentored by some of the world’s leading venture capital investors.

As a co-founder of 645 Ventures, Mr. Holiday teamed up with Nnamdi Okike to build a premier venture capital firm that is instrumental in investing seed stage startups and working closely with the founders to build growth stages businesses. The firm notably invested in FLY Labs (acquired by Google), Source3 (acquired by Facebook), ALICE (acquired by Expedia), MM LaFleur, Iterable, Overtime, Goldbely, FiscalNote, Nanit, and several other category defining companies.

645 Ventures was founded in 2014, and currently has $48 million of Assets Under Management and an aggregate portfolio value that exceeds $1 billion. The firm invests in early-stage startups in SaaS, infrastructure software, and consumer technologies, partnering with founders to build growth-stage businesses that reach large scale. The firm is backed by premier institutional LPs such as Princeton University, the Andrew W. Mellon Foundation, and Spelman College, as well as influential business and technology leaders.

Mr. Holiday graduated cum laude with a Bachelor of Science in Computer Science Morehouse College and graduated with an M.B.A. from Cornell University.


 

 
Screen Shot 2019-02-03 at 12.11.43 PM.png
Screen Shot 2019-01-24 at 1.40.06 AM.png

Andrew Adams Schoen: ‘12

New Enterprise Associates | Principal

Mr. Schoen is a Forbes 30 under 30 Venture Capital investor.

Joining New Enterprise Associates in 2014, Mr. Schoen now works as a Principal focused on enterprise and frontier technology investments. Mr. Schoen is also a member of NEA’s Asia investing team and is involved with NEA’s investments in Bytedance (Toutiao), Xsky and Zuoyebang. Prior to joining NEA, Mr. Schoen was a member of Blackstone’s M&A team in New York and co-founded the digital media company Flicstart, which was acquired.  

Mr. Schoen graduated with Phi Beta Kappa honors in Economics and Science of Earth Systems in Engineering from Cornell University and a Master in Economics from Tsinghua University in Beijing, China as a Schwarzman Scholar. Mr. Schoen serves on the Advisory Council for Entrepreneurship at Cornell and is President Emeritus of the Cornell Venture Capital Club.

 
Screen Shot 2019-02-03 at 2.30.29 PM.png
Screen Shot 2019-01-24 at 1.50.07 AM.png

Dr. Adam Goulburn

Lux Capital | Partner

Dr. Goulburn, a partner for Lux Capital, invests at the intersection of biology, healthcare, technology and data. Dr. Goulburn was an early investor in Hometeam, which uses technology to improve in-home care for our aging population; Pager, which provides consumers better access to healthcare via mobile devices; Drone Racing League, which brings drone racing to any 3-dimensional location on the planet; as well as Science 37, 3Scan, Authorea, Zipdrug, Aptible, Alluvium and RDMD.

Previously, Dr. Goulburn was the founding CEO and investor in Kallyope, which combines bioinformatics, sequencing, neuroimaging and molecular biology to decode the gut-brain axis. He has also worked with Vium, Halo Neuroscience and Kyruus.

Prior to joining Lux in 2011, Dr. Goulburn was a Postdoctoral Fellow of Neuroscience at Weill Cornell Medical College, researching regenerative stem cell medicine in association with brain disorders such as schizophrenia and Alzheimer’s disease. Dr. Goulburn has been published in numerous peer-reviewed, scientific journals.

Originally from Australia, Dr. Goulburn graduated with dual undergraduate degrees in Business and Science and a PhD from the Australian Stem Cell Centre, where he was a Premier Scholar.

 
Screen Shot 2019-03-23 at 12.08.43 PM.png
Screen Shot 2019-03-23 at 12.20.53 PM.png

Brian Harwitt: ‘15

CoVenture | Vice President

Based in New York, Mr. Harwitt works as a Vice President in Venture Debt for CoVenture, an early stage Venture Capital firm. In this capacity, he leads underwriting, diligence, and portfolio management for the direct lending portfolio, which is comprised of early-stage asset originators.

Previously Mr. Harwitt, served as the Founder and Director of the CoVenture Research Group, where he led deal sourcing efforts prime for disruption. Before his time with CoVenture, Mr. Harwitt worked as an Investment Banker for Guggenheim Partners in the Healthcare coverage group. Prior to Guggenheim, Mr. Harwitt worked as a consultant for Ernst and Young’s Business Advisory Program.

Mr. Harwitt graduated summa cum laude with a Bachelor of Science in Economics from Cornell University.

 
Screen Shot 2019-01-24 at 2.10.42 AM.png
 

Moderator: Steven Greenberg: ‘90 (MBA)

Triphammer Ventures | Managing Partner

Mr. Greenberg has over 20 years of operating and investing experience, having closed over 30 equity, debt, and M&A transactions totaling over $5 billion. Prior to managing Triphammer Ventures, a venture capital firm dedicated exclusively to Cornell alums, Mr. Greenberg was Founder and Managing Partner of Fox Meadow Capital Partners, a Private Equity and Infrastructure investment and advisory firm.

Prior to Fox Meadow, Mr. Greenberg was a General Partner for Clarity Partners, an $800 million Private Equity fund, and a Vice President for Clarity’s predecessor, Rader Reinfrank & Co., a $100 million TMT venture capital fund. While working for Clarity, Mr. Greenberg founded ImpreMedia, which he built into the largest Spanish language newspaper company in the U.S. as CFO/EVP of Corporate Development. Mr. Greenberg has also previously worked in Investment Banking and as a developer and investor in energy and utilities.

Mr. Greenberg graduated with distinction with a Bachelor of Science in Engineering from Cornell University, a J.D. from Stanford Law School, and an M.B.A. from Cornell University.